Edition:
United Kingdom

John Miller

Schindler to cut 2,000 jobs as Chinese recovery offset by global slump

24 Jul 2020

ZURICH Schindler said on Friday it will cut 2,000 jobs over two years as regions outside China reel from COVID-19 even as the Swiss elevator maker bulks up in the world's biggest lift market, which has recovered quickly from lockdowns.

WHO scientist sees regulators cooperating to speed COVID-19 vaccine approval

24 Jul 2020

Regulators that normally work within their own countries or regions will likely harmonize efforts on potential COVID-19 vaccines to speed up their approvals once they become available, WHO chief scientist Soumya Swaminathan said on Friday.

WHO scientist sees regulators cooperating to speed COVID-19 vaccine approval

24 Jul 2020

Regulators that normally work within their own countries or regions will likely harmonize efforts on potential COVID-19 vaccines to speed up their approvals once they become available, WHO chief scientist Soumya Swaminathan said on Friday.

Lonza sees no delays for COVID-19 vaccine project, citing Trump backing

24 Jul 2020

ZURICH Swiss drugmaker Lonza sees no delays for its project to make Moderna's COVID-19 vaccine candidate and has "strong support" from U.S. President Donald Trump to get the necessary manufacturing equipment, its chairman said.

Roche sales hit by lockdowns, despite COVID-19 test boost

23 Jul 2020

ZURICH A surge in demand for Roche's COVID-19 tests, as some governments even sent military jets to pick up supplies, failed to offset the hit to other parts of the healthcare company's business from the COVID-19 pandemic, it said on Thursday.

Don't expect first COVID-19 vaccinations until early 2021: WHO's Ryan

23 Jul 2020

GENEVA/ZURICH Researchers are making "good progress" in developing vaccines against COVID-19, with a handful in late-stage trials, but their first use cannot be expected until early 2021, a World Health Organization (WHO) expert said on Wednesday.

Don't expect first COVID-19 vaccinations until early 2021 - WHO's Ryan

22 Jul 2020

GENEVA/ZURICH Researchers are making "good progress" in developing vaccines against COVID-19, with a handful in late-stage trials, but their first use cannot be expected until early 2021, a World Health Organization (WHO) expert said on Wednesday.

Swiss Re to post $1.1 billion first half loss as COVID-19 claims bite

22 Jul 2020

ZURICH Reinsurance company Swiss Re said on Wednesday that claims and reserves of $2.5 billion (1.9 billion pounds) related to COVID-19 will lead to a net first half loss of about $1.1 billion.

Biogen to study Spinraza in combination with $2 mln Novartis drug

21 Jul 2020

One of medicine's costliest treatment areas could become even more pricey as Biogen seeks to layer its $750,000 spinal muscular atrophy drug on top of $2.1 million-per-patient Novartis gene therapy Zolgensma.

World News